164 related articles for article (PubMed ID: 27313612)
1. Thyroid Hormones, Autoantibodies, Ultrasonography, and Clinical Parameters for Predicting Thyroid Cancer.
He LZ; Zeng TS; Pu L; Pan SX; Xia WF; Chen LL
Int J Endocrinol; 2016; 2016():8215834. PubMed ID: 27313612
[TBL] [Abstract][Full Text] [Related]
2. A predictive model of thyroid malignancy using clinical, biochemical and sonographic parameters for patients in a multi-center setting.
Liu J; Zheng D; Li Q; Tang X; Luo Z; Yuan Z; Gao L; Zhao J
BMC Endocr Disord; 2018 Mar; 18(1):17. PubMed ID: 29514621
[TBL] [Abstract][Full Text] [Related]
3. Correlation analyses of thyroid-stimulating hormone and thyroid autoantibodies with differentiated thyroid cancer.
Zhang X; Zhang X; Chang Z; Wu C; Guo H
J BUON; 2018; 23(5):1467-1471. PubMed ID: 30570874
[TBL] [Abstract][Full Text] [Related]
4. Preoperative TSH level and risk of thyroid cancer in patients with nodular thyroid disease: nodule size contribution.
Zafón C; Obiols G; Mesa J
Endocrinol Nutr; 2015 Jan; 62(1):24-8. PubMed ID: 25066642
[TBL] [Abstract][Full Text] [Related]
5. Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules.
Kim ES; Lim DJ; Baek KH; Lee JM; Kim MK; Kwon HS; Song KH; Kang MI; Cha BY; Lee KW; Son HY
Thyroid; 2010 Aug; 20(8):885-91. PubMed ID: 20465529
[TBL] [Abstract][Full Text] [Related]
6. High Thyroglobulin Antibody Levels Increase the Risk of Differentiated Thyroid Carcinoma.
Qin J; Yu Z; Guan H; Shi L; Liu Y; Zhao N; Shan Z; Han C; Li Y; Teng W
Dis Markers; 2015; 2015():648670. PubMed ID: 26600670
[TBL] [Abstract][Full Text] [Related]
7. Monitoring differentiated thyroid cancer patients with negative serum thyroglobulin. Diagnostic implication of TSH-stimulated antithyroglobulin antibody.
Nam HY; Paeng JC; Chung JK; Kang KW; Cheon GJ; Kim Y; Park DJ; Park YJ; Min HS; Lee DS
Nuklearmedizin; 2014; 53(2):32-8. PubMed ID: 24276613
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
[TBL] [Abstract][Full Text] [Related]
9. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.
Boelaert K; Horacek J; Holder RL; Watkinson JC; Sheppard MC; Franklyn JA
J Clin Endocrinol Metab; 2006 Nov; 91(11):4295-301. PubMed ID: 16868053
[TBL] [Abstract][Full Text] [Related]
10. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.
Haymart MR; Repplinger DJ; Leverson GE; Elson DF; Sippel RS; Jaume JC; Chen H
J Clin Endocrinol Metab; 2008 Mar; 93(3):809-14. PubMed ID: 18160464
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Thyroid-Stimulating Hormone Levels and Risk of Thyroid Cancer in Post-thyroidectomy Patients for Thyroid Nodules: A Study From a Tertiary Hospital in Western Saudi Arabia.
Al-Hakami HA; Altayyeb JF; Alsharif SM; Alshareef MA; Awad BI; Al-Garni M
Cureus; 2023 Oct; 15(10):e47622. PubMed ID: 38022328
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of the value of serum TSH concentration in the diagnosis of differentiated thyroid cancer in patients with thyroid nodules.
Fan XY; You W; Chen Y; Nie CC; Wang XL; Lei C; Song J; Luo HL
Heliyon; 2024 Jan; 10(2):e24391. PubMed ID: 38312537
[TBL] [Abstract][Full Text] [Related]
13. Serum thyrotropin level of 30 μIU/mL is inadequate for preablative thyroglobulin to serve as a prognostic marker for differentiated thyroid cancer.
Zhao T; Liang J; Guo Z; Li J; Lin Y
Endocrine; 2016 Jul; 53(1):166-73. PubMed ID: 26782372
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the effect of antibodies to TSH receptors on the thyroid ultrasonographic volume in patients with Graves' disease.
Rieu M; Raynaud A; Richard A; Laplanche S; Sambor B; Berrod JL
Clin Endocrinol (Oxf); 1994 Nov; 41(5):667-71. PubMed ID: 7828357
[TBL] [Abstract][Full Text] [Related]
15. Peripheral calcification in thyroid nodules: ultrasonographic features and prediction of malignancy.
Yoon DY; Lee JW; Chang SK; Choi CS; Yun EJ; Seo YL; Kim KH; Hwang HS
J Ultrasound Med; 2007 Oct; 26(10):1349-55; quiz 1356-7. PubMed ID: 17901138
[TBL] [Abstract][Full Text] [Related]
16. Preoperative thyrotropin serum concentrations gradually increase from benign thyroid nodules to papillary thyroid microcarcinomas then to papillary thyroid cancers of larger size.
Zafon C; Obiols G; Baena JA; Castellví J; Dalama B; Mesa J
J Thyroid Res; 2012; 2012():530721. PubMed ID: 21860806
[TBL] [Abstract][Full Text] [Related]
17. The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease.
Jin J; Machekano R; McHenry CR
Am J Surg; 2010 Mar; 199(3):294-7; discussion 298. PubMed ID: 20226898
[TBL] [Abstract][Full Text] [Related]
18. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role.
Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Berti P; Grasso L; Elisei R; Pinchera A; Vitti P
Endocr Relat Cancer; 2009 Dec; 16(4):1251-60. PubMed ID: 19528244
[TBL] [Abstract][Full Text] [Related]
19. The Relationship of TPOAb and TGAb with Risk of Thyroid Nodules: A Large Epidemiological Study.
Xu W; Huo L; Chen Z; Huang Y; Jin X; Deng J; Zhu S; Yu Y
Int J Environ Res Public Health; 2017 Jul; 14(7):. PubMed ID: 28678169
[No Abstract] [Full Text] [Related]
20. Thyroid functional parameters and correlative autoantibodies as prognostic factors for differentiated thyroid cancers.
Li C; Yu W; Fan J; Li G; Tao X; Feng Y; Sun R
Oncotarget; 2016 Aug; 7(31):49930-49938. PubMed ID: 27356742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
